Updated On: 10 June, 2021 12:00 AM IST | Hyderabad | PTI
Raches Ella, who leads the Covid-19 projects at Bharat Biotech, tweeted that after submitting efficacy and 2-months of safety to Central Drugs Standard Control Organisation (CDSCO) in July, it is expected to instantly reach pre-print server. Peer review will take another 2-4 months

Photo for representational purpose
The results of third phase trials of India's first indigenously developed Covid-19 vaccine Covaxin are expected to be released next month.
Covaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started final statistical analysis.